• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP Back to Search Results
Device Problems Off-Label Use (1494); Obstruction of Flow (2423)
Patient Problem Occlusion (1984)
Event Date 09/05/2017
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing records could not be performed as device item/lot numbers were not available.Intended use / indications the gore® viabahn® endoprosthesis is indicated for improving blood flow in patients with symptomatic peripheral arterial disease in superficial femoral artery lesions with reference vessel diameters ranging from 4.0 ¿ 7.5 mm.The gore® viabahn® endoprosthesis is indicated for improving blood flow in patients with symptomatic peripheral arterial disease in iliac artery lesions with reference vessel diameters ranging from 4.0 ¿ 12 mm.Warnings ¿ w.L.Gore & associates has insufficient clinical and experimental data upon which to base any conclusions regarding the effectiveness of the gore® viabahn® endoprosthesis in applications other than the endovascular grafting of superficial femoral or iliac arteries.
 
Event Description
In a literature article titled "outcomes of chimney and/or periscope techniques in the endovascular management of complex aortic pathologies," it states 22 patients with complex aortic pathologies underwent endovascular treatment with various manufacturer devices, including gore® viabahn® endoprostheses.Twenty-two patients (17 males), ranging from 38 to 83 years with complex aortic pathologies were included in this retrospective study, from january 2013 to august 2016.Nineteen patients underwent only chimney and/or periscope techniques, while the other three underwent the chimney/periscope technique and received fenestrated/scallop stents at the same time.The complex aortic pathologies in this study refer to aortic pathologies that required repair and were accompanied by reconstructions of supra-aortic branches or visceral vessels.Twenty-six target vessels were fitted with forty chimney/periscope grafts (cpgs) and 17 gore® viabahn® endoprostheses were used.It was reported that one patient suffered an occlusion in the right renal stent in the fifth (5) month after his first procedure.This renal stent was returned to patency after the secondary procedure.The article stated seven (7) total stents were implanted in right renal artery: five bare metal stents and two cover stents.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8098239
MDR Text Key128194171
Report Number2017233-2018-00710
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 12/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age61 YR
-
-